Ryoichi Ishibashi Selected Research

Ryoichi Ishibashi Research Topics

Disease

6	Diabetes Mellitus 05/2022 - 01/2016
5	Type 2 Diabetes Mellitus (MODY) 09/2021 - 11/2012
3	Macular Edema 05/2022 - 01/2020
3	Atherosclerosis 01/2021 - 01/2016
3	Inflammation (Inflammations) 01/2016 - 11/2012
2	Transient Ischemic Attack 01/2021 - 01/2018
2	Cerebral Infarction 01/2018 - 01/2016
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2016 - 01/2012
2	Werner Syndrome (Werner's Syndrome) 08/2013 - 12/2012
1	Hyperphagia (Overeating) 09/2021
1	Diabetes Complications 09/2021
1	Heart Failure 02/2021
1	Bone Resorption 02/2021
1	Ischemic Stroke 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021
1	Myocardial Infarction 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Hyperuricemia 01/2020
1	Carotid Artery Diseases 01/2020
1	Edema (Dropsy) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency) 07/2018
1	Nephrotic Syndrome (Syndrome, Nephrotic) 07/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2016
1	Kidney Diseases (Kidney Disease) 01/2016
1	Albuminuria 01/2016
1	Infections 01/2015
1	Wounds and Injuries (Trauma) 01/2015
1	Bacteremia 01/2015
1	Hyperglycemia 08/2013
1	Dyslipidemias (Dyslipidemia) 04/2013

Drug/Important Bio-Agent (IBA)

7	SodiumIBA 05/2022 - 01/2019
7	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 11/2012
5	Sodium-Glucose Transporter 2 InhibitorsIBA 05/2021 - 01/2020
4	Sitagliptin Phosphate (Januvia)FDA Link 02/2021 - 12/2012
4	ipragliflozinIBA 02/2021 - 01/2019
3	Metformin (Glucophage)FDA LinkGeneric 02/2021 - 01/2019
2	SymportersIBA 05/2022 - 01/2021
2	Insulin (Novolin)FDA Link 05/2021 - 01/2021
2	AntibodiesIBA 01/2021 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2016
1	Retinaldehyde (Retinal)IBA 05/2022
1	Blood Glucose (Blood Sugar)IBA 05/2021
1	AcidsIBA 02/2021
1	tartaric acid (tartrate)FDA Link 02/2021
1	Tartrate-Resistant Acid PhosphataseIBA 02/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2021
1	Hemoglobins (Hemoglobin)IBA 02/2021
1	AlkaliesIBA 02/2021
1	AntigensIBA 01/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	ImmunosorbentsIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Recombinant ProteinsIBA 01/2021
1	Complementary DNA (cDNA)IBA 01/2021
1	Ranibizumab (Lucentis)FDA Link 08/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2020
1	1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA 08/2020
1	Febuxostat FDA Link 01/2020
1	Uric Acid (Urate)IBA 01/2020
1	Sodium-Glucose Transport ProteinsIBA 01/2020
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2019
1	Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)IBA 07/2018
1	Lipoproteins (Lipoprotein)IBA 07/2018
1	AdiponectinIBA 01/2016
1	Semaphorins (Semaphorin)IBA 01/2016
1	LipopolysaccharidesIBA 01/2016
1	Streptozocin (Streptozotocin)FDA Link 01/2016
1	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 01/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2015
1	Glucagon (Glukagon)FDA Link 08/2013
1	Rosuvastatin Calcium (Crestor)FDA Link 04/2013
1	Atorvastatin (Lipitor)FDA Link 04/2013
1	LipidsIBA 11/2012
1	Hypoglycemic Agents (Hypoglycemics)IBA 11/2012
1	coenzyme Q10 (CoQ10)IBA 11/2012
1	ubiquinolIBA 11/2012
1	Telmisartan (Micardis)FDA Link 01/2012

Therapy/Procedure

4	Glycemic Control 09/2021 - 11/2012
3	Therapeutics 05/2021 - 08/2020
1	Exercise Therapy (Therapy, Exercise) 01/2020